La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Bionano Genomics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Bionano Genomics..

Bionano Genomics (NASDAQ:BNGO) Azioni, Catena delle Opzioni

Bionano Genomics

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Bionano Genomics Inc

Top Win International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SORA#NASDAQ">SORA</a>), through its subsidiary, AsiaStrategy Topwin SG Pte. Ltd. ("AsiaStrategy"), has announced an intention to make a tender offer (the "Announcement") with certain other offerors for the securities of DV8 Public Company Limited (SET: DV8), a company public listed on The Stock Exchange of Thailand ("DV8").
AsiaStrategy has committed, based on the assumption that all the offerors will obtain all securities of DV8, to acquiring up to 152,842,577 ordinary shares or equivalent to 11.58 % of the total issued and paid-up share capital of DV8 and 11.58% of the unexercised warrants of DV8 as at the date where the Announcement has been launched. The offer price for the ordinary shares is THB 0.56 (fifty-six satang) per share and the offer price for the warrants is THB 0.01 (one satang) per unit. Such an offer is subject to acceptance by the security holders of DV8. The offer period is expected to close on August 20, 2025.

SORA

Top Win's AsiaStrategy To Launch Tender Offer For Up To 11.58% Of DV8 Shares And 11.58% Of DV8 Warrants At An Offering Price Of THB 0.56 And THB 0.01, Respectively

– National Footprint of NEXICART-2 Trial Sites Expanded –
–&nbsp; On track for first Biologics License Application (BLA) approved cell therapy in unaddressed orphan indication –
–&nbsp; NEXICART-2 interim results were presented at ASCO 2025 –
LOS ANGELES, CA, July 07, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced accelerated U.S. NEXICART-2 clinical trial progress in relapsed/refractory AL Amyloidosis. NEXICART-2 now includes 18 clinical trial sites in its national footprint.

News

IMMX

Immix Biopharma Accelerates U.S. NEXICART-2 Clinical Trial In Relapsed/Refractory AL Amyloidosis; Says It Is On Track For First BLA Approved Cell Therapy In Unaddressed Orphan Indication

In a 1999 interview with reporter Larry King, President&nbsp;Donald Trump, then a businessman,&nbsp;contemplated leaving the Republican Party due to a perceived lack of representation. He expressed interest in the Reform Party, a third-party option, as a potential solution.
What Happened: In a CNN interview, Trump, then a registered Republican, discussed his dissatisfaction with the political landscape. He criticized both the Democrats and Republicans for being too extreme and not addressing the issues that he and others wanted to hear about. He also highlighted a lack of national spirit, which he felt needed to be restored.
&#8220;I think that nobody is really hitting it right. The Democrats are too far left&#8230;.The Republicans are too far right. And I don&#8217;t think anybody&#8217;s hitting the cord, not the cord that I want hear, and not the cord that other people want to hear, and I&#8217;ve seen it.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Trump in 1999: Oprah would be my VP choice" width="500" height="281" src="https://www.youtube.com/embed/bc90K7Kieek?start=84&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
When King asked if a third party could be the solution, Trump responded, &#8220;Well, I think maybe we&nbsp;have no choice, and I&nbsp;think that the third party&nbsp;and the Reform Party has&nbsp;done an amazing job, but&nbsp;it&#8217;s a new party. It&#8217;s&nbsp;very, very tough to get&nbsp;elected from the Reform Party,&nbsp;we know that, but it&#8217;s a possibility, and we&#8217;re&nbsp;going to look into it.&#8221;
Trump, a former political activist for both the Democratic and Republican parties, announced&nbsp;his intention&nbsp;to form a presidential exploratory&nbsp;committee to evaluate a potential candidacy with the Reform Party, 
The Reform Party, established by&nbsp;Ross Perot&nbsp;in 1992, aimed to provide an alternative to the traditional two-party system. Despite initial interest, Trump eventually withdrew from the race&nbsp;in March 2000, conceding to&nbsp;far-right candidate&nbsp;Pat Buchanan, as reported by The Guardian.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/politics/25/07/46266046/anthony-scaramucci-wants-to-discuss-new-party-with-musk-mark-cuban-offers-ballot-access-aid" target="_blank" rel="noreferrer noopener">Anthony Scaramucci Wants &#8216;To Discuss&#8217; New Party With Musk, Mark Cuban Offers Ballot Access Aid</a>
Why It Matters: Fast forward to 2025, Donald Trump is in his second term as the President of the United States, but his musings about a third party in 1999 are particularly relevant in light of his take on recent incidents. 
On Sunday, he criticized Elon Musk over his announcement of the &#8220;America Party,&#8221; a new third-party initiative. Trump described Musk&#8217;s plan as a <a href="https://www.benzinga.com/news/politics/25/07/46266957/trump-calls-america-party-a-train-wreck-blasts-elon-musk-for-going-completely-off-the-rails-president-says-system-not-designed-for-a-third-player">&#8220;Train Wreck,&#8221; </a>arguing that the American political system is not designed to accommodate third parties, which he believes only leads to &#8220;Disruption &amp; Chaos.&#8221; 
The friction between Trump and Musk has been a topic of discussion, especially after Musk criticized Trump&#8217;s &#8220;Big Beautiful Bill,&#8221; a tax and spending package adding $3.8 trillion to the deficit. This growing rift between the tech world and Trump&#8217;s MAGA movement has <a href="https://www.benzinga.com/markets/tech/25/07/46268414/as-elon-musks-rift-with-donald-trump-deepens-former-google-executive-says-maga-and-tech-world-cant-thrive-without-each-other">raised concerns</a> about potential impacts on both political and technological progress, as discussed by panelists on the All-In Podcast, including David Friedberg and Chamath Palihapitiya. 
The tension underscores the challenges of bridging the gap between political ideologies and technological advancements.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/politics/25/07/46266316/donald-trumps-approval-rating-jumps-among-baby-boomers-heres-whats-driving-it" target="_blank" rel="noreferrer noopener">Donald Trump's Approval Rating Jumps Among Baby Boomers — Here's What's Driving It &#8211; Benzinga</a></li>
</ul>
 Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Elon Musk's Third-Party Talk Isn't New — Donald Trump Once Explored A Presidential Run Outside GOP, Frustrated With America's Political System: 'Nobody Is Really Hitting It Right'

Trading Ideas

BMNR

BitMine Immersion Technologies Shares Halted On Circuit Breaker To The Upside, Stock Now Down -14.0%

La Rosa Holdings Corp. (NASDAQ:&nbsp;LRHC) ("La Rosa" or the "Company"), a real estate and PropTech company, today announced the launch of My Agent Account Version 4.0, a major enhancement to the Company's proprietary agent platform. The new version, which went live on July 1, 2025, features a fully integrated Transaction Management module that is intended to deliver significant cost savings to the Company by improving efficiency, reducing manual processes, and eliminating reliance on expensive third-party systems.
My Agent Account, La Rosa's proprietary platform, was designed to empower agents with a comprehensive suite of tools and resources. Serving as a centralized hub, it enables agents by streamlining daily operations, consolidating essential business tools, and reducing administrative workload. With the introduction of the new transaction module, La Rosa has significantly improved the platform's ability to manage workflows. All La Rosa agents have access to My Agent Account and are required to pay an annual subscription fee per agent for it.

LRHC

La Rosa Launches My Agent Account 4.0 With Integrated Transaction Management To Cut Costs And Streamline Agent Operations

IREN Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) shares are volatile Monday morning after rising approximately 20% over the past week. Here&#8217;s a look at <a href="https://www.benzinga.com/pressreleases/25/07/g46270948/iren-june-2025-monthly-update">what&#8217;s going on</a>. 
What To Know: IREN on Monday provided a mining update for June showing that the company mined 620 Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) last month. IREN said it generated record monthly revenues driven by higher Bitcoin prices despite mining seven less Bitcoin than in May. 
The company said it reached its hashrate target of 50 EH/s by the end of the month and had an average operating hashrate of 41.1 EH/s during the period. 
&#8220;The past month has marked several significant milestones for IREN. We delivered another month of record revenues, executed an oversubscribed convertible note offering, reached our self-mining target of 50 EH/s, transitioned to U.S. domestic issuer status, and more than doubled our AI Cloud business with the procurement of next-generation NVIDIA Blackwell GPUs,&#8221; said Daniel Roberts, co-founder and co-CEO of IREN.
The update comes after IREN shares rallied 7.41% on Thursday after announcing that it expanded its AI cloud through the purchase of&nbsp;2,400 Nvidia Blackwell GPUs.
The 2,400 Blackwell GPUs, consisting of 1,300 B200 GPUs and 1,100 B300 GPUs, are expected to be installed over the coming months at IREN's Prince George, British Columbia campus.&nbsp;The company said it expects the GPU deployment to deliver attractive risk-adjusted returns on a stand-alone basis.
&#8220;IREN is at the forefront of two transformative technologies, Bitcoin and AI, owning and operating the compute infrastructure that powers both,&#8221; Roberts said.
IREN Price Action: <a href="http://benzinga.com/quote/IREN" target="_blank" rel="noreferrer noopener">IREN shares</a> were up over 3% in pre-market trading Monday before pulling back. The stock was down 7.25% at $15.69 at the time of publication, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46272572/scottie-pippen-is-watching-bitcoin-xrp-dogecoin-and-what-else">Scottie Pippen Is Watching Bitcoin, XRP, Dogecoin&#8230;And What Else?</a></li>
</ul>
Photo: egaranugrah/Shutterstock.com

Movers

$BTC

IREN

IREN Stock Is Trending Today: What's Going On?

BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOSC#NASDAQ">BOSC</a>), a global integrator of supply chain technologies, today announced that it has secured orders totaling $425,000 from new customers in India.
The orders are for wiring and cabling products that BOS began offering at the end of 2024. These products complement the electromechanical connectors that BOS currently supplies, enabling the Company to increase its revenues, particularly within the defense sector.

BOSC

BOS Better Online Solutions Secures Orders Totaling $425K For Wiring And Cabling Products From New Customers In India

ABVE

Above Food Ingredients Shares Halted On Circuit Breaker To The Downside, Stock Now Up 60%

Webull Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) shares are trading lower Monday after the company announced a $1 billion <a href="https://www.benzinga.com/news/25/07/46270242/why-apogee-therapeutics-shares-are-trading-higher-by-50-here-are-20-stocks-moving-premarket">standby equity agreement</a>.
What To Know:&nbsp;Webull on Thursday announced the securing of a financing option with YA II PN, an investment fund managed by Yorkville Advisors, through a standby equity purchase agreement.
The agreement gives Webull the option to issue up to&nbsp;$1 billion&nbsp;in Class A ordinary shares to Yorkville over a three-year period. Yorkville will pay a 2.5% discount to the market price for any shares issued under the purchase agreement.
Webull plans to use the agreement to strategically raise and deploy capital as it needs.
"With access to capital available through the Purchase Agreement, Webull is well positioned to pursue new growth opportunities, such as product expansion, new asset classes, and geographic expansion," said&nbsp;Anthony Denier, group president and U.S. CEO of Webull.&nbsp;
"As we survey the evolving market landscape and consider next-generation technologies in the space such as stable coins and real-world asset tokenization, access to capital will be critical to our ability to innovate and compete on the cutting edge going forward."
<h3 class="wp-block-heading">How To Buy BULL Stock</h3>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Webull's case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
BULL Price Action: <a href="http://benzinga.com/quote/BULL">Webull shares</a> were down 12.1% at $12.57 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46269226/stocks-just-hit-rare-golden-cross-for-1st-time-since-2023-heres-what-it-means-for-investors">Stocks Just Hit Rare Golden Cross For 1st Time Since 2023 — Here&#8217;s What It Means For Investors</a></li>
</ul>
Photo: Tada Images / Shutterstock.com

BULL

What's Going On With Webull Stock?

WIIM

APOG

APOG stock has given up its prior gain. Apogee Therapeutics shares were trading higher after the company released 16-week data from Part A of the Phase 2 APEX clinical trial of APG777 for moderate-to-severe atopic dermatitis.

Shell plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) on Monday released its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46267878/shell-second-quarter-2025-update-note" rel="noreferrer noopener">updated financial outlook</a> for the second quarter of 2025, ahead of its scheduled July 31 earnings report. The guidance outlines expected performance across major business segments, including gas production, marketing, chemicals, and renewables.
Output from integrated gas operations is projected to be between 900,000 and 940,000 barrels of oil equivalent per day, compared to 927,000 barrels of oil equivalent per day in the first quarter. LNG liquefaction volumes are estimated to be between 6.4 and 6.8 million metric tons, versus 6.6 million metric tons in the first quarter.
Upstream production is set to decline to a range of 1.66 million to 1.76 million barrels per day, down from 1.855 million in the first quarter,&nbsp;following scheduled maintenance and the completed sale of assets in Nigeria.
Also Read: <a target="_blank" href="https://www.benzinga.com/m-a/25/06/46112992/shell-squashes-bp-takeover-rumors-hits-six-month-ban" rel="noreferrer noopener">Shell Squashes BP Takeover Rumors, Hits Six-Month Ban</a>
Shell anticipates stronger adjusted earnings in its marketing division compared to the first quarter, supported by projected sales volumes between 2.6 million and 3 million barrels per day. However, trading and optimization activity is expected to drop sharply across several segments, signaling a broader weakness in market conditions.
While Shell expects improved margins in its refining and chemicals businesses, $8.9 per barrel (from $6.2) for refining and $166 per metric ton (from $126) for chemicals, the company said adjusted earnings from the Chemicals and Products segment will likely fall below breakeven.
Refinery utilization is forecast at 92–96% (up from 85%), while chemicals utilization is set to fall to 68–72% (from 81%) due to maintenance at the Monaca facility. Operating expenses are expected to be between $1.7 billion and $2.1 billion.
Renewables and Energy Solutions could report an earnings loss of up to $400 million or a gain of up to $200 million. Shell attributes the wide range to continued weakness in trading activity. Meanwhile, its corporate unit is projected to post an adjusted loss between $400 million and $600 million.
At the group level, Shell expects to pay between $2.8 billion and $3.6 billion in taxes for the quarter. Derivative movements could swing from a $1 billion loss to a $3 billion gain. Working capital is expected to vary significantly, ranging from a $1 billion outflow to a $4 billion inflow, contributing to uncertainty around overall cash flow from operations.
Shell&#8217;s full earnings report for the second quarter is due July 31.
Related ETFs: Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>), iShares Global Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IXC#NYSE">IXC</a>).
Price Action: SHEL shares are trading lower by 2.88% to $69.85 premarket at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46270052/as-trumps-big-beautiful-bill-is-signed-into-law-these-evs-from-tesla-gm-and-ford-will-become-more-expensive" target="_blank" rel="noreferrer noopener">As Trump&#8217;s &#8216;Big, Beautiful Bill&#8217; Is Signed Into Law, These EVs From Tesla, GM And Ford Will Become More Expensive: Report</a></li>
</ul>
Photo by FotograFFF via Shutterstock

Large Cap

Guidance

SHEL

Shell Sees Lower Production, Softer Trading In Q2

His Highness Sheikh Mohammed Bin Maktoum Bin Juma Al Maktoum of the Dubai Royal Family Appointed to Board Of Directors
Merger Adds Billions of Dollars in Gold-Based Assets to Above Food's Balance Sheet, Positioning the Company as a Global Leader in the Issuance of Stablecoins and Asset Tokenisation with Considerable Recurring Revenues
Regina, Saskatchewan--(Newsfile Corp. - July 7, 2025) - Above Food Ingredients Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVE#NASDAQ">ABVE</a>) ("Above Food") is pleased to announce that it has executed a definitive business combination agreement ("Merger Agreement") with Palm Global Technologies Ltd. ("Palm Global") effective July [7], 2025. Under this agreement, Above Food and Palm Global will combine (the "Merger") through a statutory plan of arrangement in Above Food's domestic jurisdiction. The proposed transaction has received unanimous approval from the boards of directors of both Above Food and Palm Global.
The reverse takeover merger is poised to transform Above Food, adding Palm Global's 30% stake in the Palm Promax Investments ("PPI") joint venture onto its balance sheet. This includes Palm Global's share of PPI's $350 billion valuation of U.S. situated gold-based assets. Under the terms of the Merger, Above Food will acquire Palm Global, with the latter's shareholders receiving a total of 1.1 billion shares in Above Food in exchange for their existing holding.
Through this Merger, Above Food is positioned to become a market leader in the tokenization of real-world assets and the issuance of stablecoins, underpinned by its unequalled access to over $1.5 trillion of diverse AA- and AAA-rated sovereign-owned assets via its joint venture partner, Promax United.
Amid the recent global focus toward establishing stablecoin standards, underscored by the passage of the GENIUS (Guiding and Establishing National Innovation in U.S. Stablecoins) Act in the U.S. Senate, alongside corresponding legislation such as MiCA (Markets in Cryptocurrency Act) in the EU, draft regulations in the UK, and the Stablecoins Ordinance Regime in Hong Kong, PPI is positioned to emerge as a global leader in both the issuance of stablecoins and the establishment of central bank digital currency frameworks for developing nations, with over 15 sovereign partners already committed to the initiative.
Transaction Benefits to Above Food
<ol>
<li>Transformative and immediate uplift in Above Food's balance sheet through Palm Global's 30% ownership of PPI and its $350 billion valuation of gold-based assets;</li>
<li>Direct access to over $1.5 trillion of sovereign-owned assets to tokenize, leading to significant recurring long-tail income streams;</li>
<li>Equity partner and technology provider in venture set to become a market leading issuer of stablecoins and multinational central bank digital currencies, facilitating the generation of considerable revenues;</li>
<li>Accelerated growth in agricultural and food product revenue and margins through immediate entry into new markets and strategic trading partnerships; and</li>
<li>Joint ventures and partnerships with ruling sovereign families and world renown global institutions.</li>
</ol>

Management

Global

Above Food Merges With Palm Global, Adding 30% Stake In $350B Gold-Based Assets; Appoints Dubai Royal Sheikh Mohammed Bin Maktoum To Board; Gains Access To $1.5T In Sovereign Assets For Stablecoin And Asset Tokenization Leadership; Anticipates That The Combined Co's Shares Will Trade On The Nasdaq Capital Market

Cogent Biosciences, Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COGT#NASDAQ">COGT</a>) bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. 
With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration approval by the end of 2025. 
The results not only validate Cogent's targeted approach but also position bezuclastinib as a potential first-in-class therapy for a condition with limited treatment options.
<a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">Systemic mastocytosis (NonAdvSM)</a> is a rare disease characterized by the abnormal accumulation of mast cells in various tissues, including the bone marrow, skin, and other organs.
The latest study demonstrated meaningful and highly statistically significant improvements across the primary and all key secondary endpoints, including patient-reported symptoms and <a href="https://www.benzinga.com/pressreleases/25/07/g46270932/cogent-biosciences-announces-positive-top-line-results-achieving-statistical-significance-across-a" target="_blank" rel="noreferrer noopener">objective measures of mast cell burden</a>.
Also Read: <a href="https://www.benzinga.com/24/11/41987123/blood-cancer-focused-blueprint-medicines-could-be-attractive-target-for-partnerships-analyst-initiates-with-around-30-upside" target="_blank" rel="noreferrer noopener">Blood Cancer-Focused Blueprint Medicines Could Be &#8216;Attractive Target For Partnerships&#8217;: Analyst</a>
Based on these data, Cogent is on track to submit its first new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for bezuclastinib in NonAdvSM by the end of 2025.
In addition, Cogent plans to present detailed results from the SUMMIT trial at an upcoming medical meeting later this year.
The SUMMIT trial achieved its primary endpoint with a statistically significant difference in the mean change in total symptom score (TSS) at 24 weeks.
The bezuclastinib arm had a mean reduction of 24.3 points in TSS at 24 weeks, versus the placebo arm, which had a mean reduction of 15.4 points, resulting in a placebo-adjusted TSS improvement of 8.91 points.
In addition, the SUMMIT trial demonstrated statistically significant benefit across all key secondary endpoints, including reduction of serum tryptase on which 87.4% of bezuclastinib-treated patients had ≥50% reduction, compared to no patients in the control arm (87.4% vs. 0%).
Complete analysis of the full SUMMIT Part 2 data is ongoing, and Cogent plans to present detailed results at a major medical conference later this year.
Cogent remains on track to provide topline results from both PEAK, a Phase 3 trial of bezuclastinib in combination with sunitinib in patients with gastrointestinal stromal tumors, and APEX, a registration-directed trial of bezuclastinib in advanced systemic mastocytosis patients, during the second half of 2025.
The company has a cash balance of $237 million and access to an additional $350 million via a recently announced debt facility with SLR Capital Partners.
Price Action: At the last check on Monday, COGT stock was up 15.7% at $8.77 during the premarket session.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46269806/pony-ai-to-deploy-robotaxis-in-dubai-trials-begin-late-2025" target="_blank" rel="noreferrer noopener">Pony.ai To Deploy Robotaxis In Dubai, Trials Begin Late 2025</a></li>
</ul>
Image: Shutterstock

Biotech

Health Care

General

COGT

Why Is Cogent Biosciences Stock Trading Higher On Monday?

Tesla is swimming in contradiction. On the one hand, it&#8217;s a $1 trillion behemoth, rivaling the economy of an entire small nation. On the other hand, investors are jittery: shares are down about 17 % year-to-date, and profits and deliveries have just <a href="https://www.benzinga.com/topic/tesla">hit multi-quarter lows.</a>
The culprit? CEO Elon Musk's escalating political ambitions—and a glaring lack of an alternative CEO.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46268694/elon-musks-america-party-plans-conflict-with-his-full-time-responsibilities-as-tesla-ceo-says-former-doge-advisor">Elon Musk&#8217;s America Party Plans &#8216;Conflict&#8217; With His Full-Time Responsibilities As Tesla CEO, Says Former DOGE Advisor</a>
<h2 class="wp-block-heading">Musk's America Party Rocks Tesla's World</h2>
Tesla's stock dropped nearly 7 % in pre-market trading on Monday after Musk unveiled his "America Party," reviving investor fears that he's losing focus on the automaker's core mission.
Concerns extend beyond political squabbles: analysts like Neil Wilson from Saxo Markets warn that Musk's political distraction could jeopardize subsidies and contracts, potentially pushing the stock from a &#8220;vision premium&#8221; to a governance discount, according to Reuters.
<h2 class="wp-block-heading">No Plan B: Tesla's Leadership Vacuum</h2>
It's not just that Musk might start spending more time with lobbyists than on factory floors. Institutional investors are now demanding that he commit full-time to Tesla<a href="https://www.washingtonpost.com/technology/2025/05/28/musk-tesla-board-succession-plan/">,</a> with a minimum of 40 <a href="https://www.washingtonpost.com/technology/2025/05/28/musk-tesla-board-succession-plan/">hours</a> per week, amid falling profits and stagnating sales, according to The Washington Post.
Tesla has no clear succession plan. There&#8217;s no Tim Cook waiting in the wings—just Tom Zhu's low-profile stint in China. For a company trading at ~180x P/E, that's not just risky &#8211; it's existential.
<h2 class="wp-block-heading">Valuation On Thin Ice</h2>
Tesla's valuation is sky-high:
<ul class="wp-block-list">
<li>P/E (TTM): 180x</li>
<li>Forward P/E: 164x</li>
<li>EV/EBITDA: ~73x</li>
<li>PS ratio: ~11.6x</li>
</ul>
Data Source: <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0707">Benzinga Pro</a>
At these multiples, markets aren't just pricing in Tesla's EV future &#8211; they're betting Musk stays at the wheel every day. That's a tall order &#8211; even for the world's richest man.
<h2 class="wp-block-heading">The &#8216;Musk Premium&#8217; On Thin Ice</h2>
Tesla's growth story depends not just on innovation &#8211; but on uninterrupted leadership. As Musk flips the script toward politics, the "Musk premium" powering Tesla stock is buckling.
Without a concrete succession plan or a disciplined CEO, that premium could quickly evaporate. And Tesla's valuation may be riding on ice that's about to crack.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46261711/forget-robotaxis-ford-just-drove-straight-into-teslas-valuation-problem">Forget Robotaxis &#8211; Ford Just Drove Straight Into Tesla&#8217;s Valuation Problem</a></li>
</ul>
Photo: Jonathan Weiss on Shutterstock.com

Long Ideas

Tech

TSLA

No Plan B - Tesla's Musk Premium Is On Thin Ice

Offerings

AMBR

Amber International Files For Mixed Shelf Offering Of Up To $500M

Citigroup analyst Matthew Herrmann initiates coverage on Ategrity Specialty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIC#NYSE">ASIC</a>) with a Neutral rating and announces Price Target of $26.

Price Target

Initiation

Analyst Ratings

ASIC

Citigroup Initiates Coverage On Ategrity Specialty with Neutral Rating, Announces Price Target of $26

Agreement provides for the launch of the remaining nine replacement satellites under construction by Macdonald, Dettwiler and Associates Corporation ("MDA")
Globalstar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSAT#NASDAQ">GSAT</a>), a next-generation telecommunications infrastructure and technology provider, today announces that the Company has signed an agreement with SpaceX for a Falcon 9 launch for the next set of satellites, pursuant to the 2022 satellite procurement agreement with MDA. As previously disclosed, these satellites will provide continuous satellite services in combination with the existing second-generation satellites in operation today. Globalstar expects the launch will take place next year following the initial launch this year. These satellites have been authorized by the Federal Communications Commission to operate under Globalstar's HIBLEO-4 filing for a renewed 15-year term.

GSAT

Globalstar Signs Agreement With SpaceX For Falcon 9 Launch For Next Set Of Satellites, Pursuant To 2022 Satellite Procurement Agreement With MDA

Funko, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>), a leading pop culture lifestyle brand, today announced that Michael Lunsford has been appointed as the Company's Interim Chief Executive Officer, effective July 5, 2025. The appointment follows the departure of Cynthia Williams from her role as the Company's Chief Executive Officer, effective on the same date. Mr. Lunsford previously served as Funko's Interim Chief Executive Officer in 2023-2024 and continues to serve as a member of the Company's Board of Directors.
 &nbsp;

FNKO

Funko Appoints Michael Lunsford As Interim CEO, Effective July 5, 2025; CEO Cynthia Williams Departs

When it comes to protecting your financial legacy, Suze Orman has one clear message: the only version of your key documents that counts is the original. In a recent "<a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-throwing-money-at-a-problem-does-not-always-solve-it">Women &amp; Money</a>" podcast episode, Orman and her partner, KT, addressed a listener's question about where to safely store important estate planning paperwork.&nbsp;
With natural disasters on the rise and digital copies gaining popularity, it's easy to assume a backup is enough. But according to <a href="https://www.benzinga.com/personal-finance/crowdsourcing/25/06/46157633/suze-orman-believes-the-stock-market-will-continue-climbing-without-a-shadow-of-a-doubt">Orman</a>, that's not the case.
Here's what you need to know about storing your will, trust, and other legal documents — and why originals matter most.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
<h2 class="wp-block-heading">Originals Only: Copies Won't Cut It</h2>
Listener Sherry asked whether she could give signed duplicates of her <a href="https://www.benzinga.com/personal-finance/25/05/45632293/this-119-will-trust-kit-could-save-your-family-thousands-and-its-now-20-off">estate documents</a> to family members in case the originals were destroyed. Orman didn't hesitate: "No. They are not valid."&nbsp;
In the eyes of the law, photocopies or digital scans of legal documents like a will or trust won't hold up if challenged — the original signed and notarized version is the only one that counts.
That doesn't mean copies are useless. Orman said it's still wise to share your intentions with loved ones. Even if they don't have a valid document in hand, they'll know what your wishes are and can act accordingly — especially in an emergency.
<h2 class="wp-block-heading">Best Place to Store Must-Have Documents</h2>
So, where should you keep those crucial originals? Orman recommends storing them at home in a fireproof and waterproof box. She previously sold her own line of such boxes, but even without those on the market today, similar products are widely available.&nbsp;
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
The key is to ensure the box can withstand extreme conditions — including fire, flood, or <a href="https://www.benzinga.com/news/topics/25/06/45828329/veteran-florida-weatherman-says-hes-struggling-to-forecast-hurricanes-blames-the-gutting-the-sledgehammer-attack-on-science">hurricane</a> — and is easy to grab in an emergency.
Another option is to store your documents at a trusted relative's home, especially someone who would be involved in carrying out your estate plans. If disaster strikes your area, having the documents elsewhere could be a lifesaver.&nbsp;
Just make sure this person knows exactly where the documents are and is able to take them along during an evacuation.
<h2 class="wp-block-heading">What About Safe Deposit Boxes?</h2>
Storing documents in a bank's safe deposit box may seem like a secure choice, but Orman cautions against relying on this alone. If something happens to you — or to the bank itself — your family may not be able to access what they need. Banks may be closed, damaged, or destroyed during a natural disaster. And unless your loved ones are listed on the box, they could face delays getting in, even if they know it exists.
If you do go this route, make sure more than one trusted person is named on the box and is aware of its contents and importance.
See Also: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a>
<h2 class="wp-block-heading">Replacing Lost Documents</h2>
If the worst happens and your original documents are destroyed, don't panic. Orman reassures listeners that you can reprint them — assuming they were created digitally — and simply get them notarized again. They'll then be valid once more.
If you're just starting the process, Orman recommends using musthavedocs.com, a platform she supports that offers $2,500 worth of legal documents for $99, valid in all 50 states.
Bottom line: The only valid documents are the originals. Store them in a fireproof, waterproof container — either at home or with someone you trust — and make sure your family knows where to find them.
Read Next: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Image: Shutterstock

Personal Finance

Suze Orman: Only Originals Are Valid — Here's Where to Keep Your Must-Have Docs So They Survive Anything

<ul>
<li>TSLA</li>
<li>BULL</li>
<li>GLD</li>
<li>NVDA</li>
<li>GOOGL</li>
<li>UNH</li>
<li>AAPL</li>
<li>HOOD</li>
<li>J</li>
<li>NET</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

GOOGL

HOOD

NVDA

Top 10 Trending Stocks On WallStreetBets As Of July 7, 2025 (Via Swaggy Stocks)

Press Releases

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Earnings

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy

Comments

Bionano Genomics

Bionano Genomics (BNGO) Opzioni

Bionano Genomics (NASDAQ:BNGO) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO